- Home
- WWR vs GNLX Comparison
WWR vs GNLX Comparison
Compare WWR & GNLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$0.88
HOLD
Current Price
$2.58
Company Overview
Basic Information| Metric | WWR | GNLX |
|---|---|---|
| Founded | 1977 | 2001 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Metal Mining | Biotechnology: Pharmaceutical Preparations |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 114.3M | 108.2M |
| IPO Year | N/A | 2023 |
Fundamental Metrics
Financial Performance| Metric | WWR | GNLX |
|---|---|---|
| Price | $0.88 | $2.58 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 4 |
| Target Price | $1.88 | ★ $19.75 |
| AVG Volume (30 Days) | ★ 2.7M | 236.4K |
| Earning Date | 03-19-2026 | 03-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.45 | $1.99 |
| 52 Week High | $3.75 | $8.54 |
Technical Indicators
Market Signals| Indicator | WWR | GNLX |
|---|---|---|
| Relative Strength Index (RSI) | 41.25 | 34.21 |
| Support Level | $0.84 | $2.36 |
| Resistance Level | $0.98 | $2.66 |
| Average True Range (ATR) | 0.09 | 0.17 |
| MACD | -0.02 | 0.04 |
| Stochastic Oscillator | 8.88 | 25.97 |
Price Performance
Historical Comparison WWR
GNLX
About WWR Westwater Resources Inc.
Westwater Resources Inc focused on developing battery-grade natural graphite materials. The company is having one project which is the Westwater's coosa project which is currently used for the mining and extraction of graphite.
About GNLX Genelux Corporation
Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products include Olvi-Vec (olvimulogene nanivacirepvec), Lung, and Pancreatic Cancer.